Estrogen-signaling pathway: A link between breast cancer and melatonin oncostatic actions

Cos, 2000, Melatonin and mammary pathological growth, Front Neuroendocrinol, 21, 133, 10.1006/frne.1999.0194

Cos, 2000, Melatonin, experimental basis for a possible application in breast cancer prevention and treatment, Histol Histopathol, 15, 637

Blask, 2002, Melatonin as a chronobiotic/anticancer agent: cellular, biochemical and molecular mechanisms of action and their implications for circadian-based cancer therapy, Curr Top Med Chem, 2, 113, 10.2174/1568026023394407

Sánchez-Barceló, 2003, Melatonin and mammary cancer: a short review, Endocr Relat Cancer, 10, 153, 10.1677/erc.0.0100153

Reiter, 1980, The pineal and its hormones in the control of reproduction in mammals, Endocr Rev, 1, 109, 10.1210/edrv-1-2-109

Molis, 1994, Modulation of estrogen receptor mRNA expression by melatonin in MCF-7 human breast cancer cells, Mol Endocrinol, 8, 1681, 10.1210/me.8.12.1681

Cos, 1991, Effects of melatonin on the cell cycle kinetics and estrogen rescue of MCF-7 human breast cancer cells in culture, J Pineal Res, 10, 36, 10.1111/j.1600-079X.1991.tb00007.x

Fraschini, 1998, Melatonin involvement in immunity and cancer, Biol Signals Recept, 7, 61, 10.1159/000014529

Allegra, 2003, The chemistry of melatonin's interaction with reactive species, J Pineal Res, 34, 1, 10.1034/j.1600-079X.2003.02112.x

Leon-Blanco, 2003, Melatonin inhibits telomerase activity in the MCF-7 tumor cell line both in vivo and in vitro, J Pineal Res, 35, 204, 10.1034/j.1600-079X.2003.00077.x

Dumitrescu, 2005, Understanding breast cancer risk—where do we stand in 2005?, J Cell Mol Med, 9, 208, 10.1111/j.1582-4934.2005.tb00350.x

Russo, 1998, Role of hormones in mammary cancer initiation and progression, J Mammary Gland Biol Neoplasia, 3, 49, 10.1023/A:1018770218022

Howell, 1997, Oestrogens, Beatson and endocrine therapy, Endocr Relat Cancer, 4, 371, 10.1677/erc.0.0040371

Preston-Martin, 1990, Increased cell division as a cause of human cancer, Cancer Res, 50, 7415

Yue, 2003, Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis, J Steroid Biochem Mol Biol, 86, 477, 10.1016/S0960-0760(03)00377-7

Landeghem, 1985, Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue, Cancer Res, 45, 2900

Yue, 1998, In situ aromatization enhances breast tumor estradiol levels and cellular proliferation, Cancer Res, 58, 927

Wong, 2004, First-line endocrine treatment of breast cancer: aromatase inhibitor or antiestrogen?, Br J Cancer, 90, 20, 10.1038/sj.bjc.6601508

Lerner, 1958, Isolation of melatonin, the pineal gland factor that lightens melanocytes, J Am Chem Soc, 80, 2587, 10.1021/ja01543a060

Vanecek, 1998, Cellular mechanisms of melatonin action, Physiol Rev, 78, 687, 10.1152/physrev.1998.78.3.687

Becker-Andre, 1994, Pineal gland hormone melatonin binds and activates an orphan of the nuclear receptor superfamily, J Biol Chem, 269, 28531, 10.1016/S0021-9258(19)61934-4

Anton-Tay, 1998, Modulation of the subcellular distribution of calmodulin by melatonin in MDCK cells, J Pineal Res, 24, 35, 10.1111/j.1600-079X.1998.tb00363.x

Arendt, 1986, Role of the pineal gland and melatonin in seasonal reproductive function in mammals, Oxf Rev Reprod Biol, 8, 266

Malpaux, 2001, Biology of mammalian photoperiodism and the critical role of the pineal gland and melatonin, J Biol Rhythms, 16, 336, 10.1177/074873001129002051

Dubocovich, 2003, Molecular pharmacology, regulation and function of mammalian melatonin receptors, Front Biosci, 8, 1093, 10.2741/1089

Yellon, 1986, Melatonin rhythms time photoperiod-induced puberty in the female lamb, Endocrinology, 119, 44, 10.1210/endo-119-1-44

Kauppila, 1987, Inverse seasonal relationship between melatonin and ovarian activity in humans in a region with a strong seasonal contrast in luminosity, J Clin Endocrinol Metab, 65, 823, 10.1210/jcem-65-5-823

Luboshitzky, 1999, Melatonin and sex hormone interrelationships—a review, J Pediatr Endocrinol Metab, 12, 355, 10.1515/JPEM.1999.12.3.355

Woo, 2001, Direct action of melatonin in human granulosa-luteal cells, J Clin Endocrinol Metab, 86, 4789, 10.1210/jc.86.10.4789

Webley, 1986, Melatonin directly stimulates the secretion of progesterone by human and bovine granulosa cells in vitro, J Reprod Fertil, 78, 711, 10.1530/jrf.0.0780711

Cohen, 1978, Role of pineal gland in aetiology and treatment of breast cancer, Lancet, 2, 814, 10.1016/S0140-6736(78)92591-6

Tamarkin, 1982, Decreased nocturnal plasma melatonin peak in patients with estrogen receptor positive breast cancer, Science, 216, 1003, 10.1126/science.7079745

Maestroni, 1996, Melatonin in human breast cancer tissue: association with nuclear grade and estrogen receptor status, Lab Invest, 75, 557

Bartsch, 1981, Urinary melatonin levels in human breast cancer patients, J Neural Transm, 52, 281, 10.1007/BF01256753

Brzezinski, 1997, Melatonin in humans, N Engl J Med, 336, 186, 10.1056/NEJM199701163360306

Soule, 1973, A human cell line from a pleural effusion derived from a breast carcinoma, J Natl Cancer Inst, 51, 1409, 10.1093/jnci/51.5.1409

Brooks, 1973, Estrogen receptor in a human breast tumor cell line (MCF-7) from breast carcinoma, J Biol Chem, 248, 6251, 10.1016/S0021-9258(19)43537-0

Lippman, 1976, The effects of estrogen and antiestrogen on hormone-responsive human breast cancer in long-term tissue culture, Cancer Res, 36, 4595

Adams, 1983, Hormone action in human breast cancer, 1

Yuan, 2002, MT-1 melatonin receptor overexpression enhances the growth suppressive effect of melatonin in human breast cancer cells, Mol Cell Endocrinol, 192, 147, 10.1016/S0303-7207(02)00029-1

Ram, 2002, Involvement of the MT-1 melatonin receptor in human breast cancer, Cancer Lett, 179, 141, 10.1016/S0304-3835(01)00873-4

Blask, 1986, Effects of melatonin on cancer: studies on MCF-7 human breast cancer cells in culture, J Neural Transm, 21, 433

Hill, 1992, The growth inhibitory action of melatonin on human breast cancer cells is linked to the estrogen response system, Cancer Lett, 64, 249, 10.1016/0304-3835(92)90050-6

Cos, 1996, Melatonin inhibits DNA synthesis in MCF-7 human breast cancer cells in vitro, Life Sci, 58, 2447, 10.1016/0024-3205(96)00249-4

Cos, 1994, Melatonin modulates growth factor activity in MCF-7 human breast cancer cells, J Pineal Res, 17, 25, 10.1111/j.1600-079X.1994.tb00110.x

Molis, 1993, Melatonin modulation of estrogen receptor expression in MCF-7 human breast cancer cells, Int J Oncol, 3, 687

Molis, 1995, Melatonin modulation of estrogen-regulated proteins, growth factors and proto-oncogenes in human breast cancer, J Pineal Res, 18, 93, 10.1111/j.1600-079X.1995.tb00146.x

Osborne, 1985, Effects of estrogens and antiestrogens on human breast cancer cell proliferation: in vitro studies in tissue culture and in vivo studies in athymic mice, 93

Cos, 1996, Modulation of the length of the cell cycle time of MCF-7 human breast cancer cells by melatonin, Life Sci, 58, 811, 10.1016/0024-3205(95)02359-3

Mediavilla, 1999, Melatonin increases p53 and p21waf1 expression in MCF-7 human breast cancer cells in vitro, Life Sci, 65, 415, 10.1016/S0024-3205(99)00262-3

Malamud, 1971, 132

Crespo, 1994, Interaction between melatonin and estradiol on morphological and morphometric features of MCF-7 human breast cancer cells, J Pineal Res, 16, 215, 10.1111/j.1600-079X.1994.tb00105.x

Albini, 1986, 17β-Estradiol regulates and v-Ha-ras transfection constitutively enhances MCF-7 breast cancer cell interactions with basement membrane, Proc Natl Acad Sci USA, 83, 8182, 10.1073/pnas.83.21.8182

Cos, 1998, Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells, Cancer Res, 58, 4383

Gui, 1997, Altered cell–matrix contact: a prerequisite for breast cancer metastasis?, Br J Cancer, 75, 623, 10.1038/bjc.1997.113

Trosko, 1990, Chemical, oncogene and growth factor inhibition of gap junctional intercellular communication: an integrative hypothesis of carcinogenesis, Pathobiology, 58, 265, 10.1159/000163596

Cos, 2000, Melatonin effects on intercellular junctional communication in MCF-7 human breast cancer cells, J Pineal Res, 29, 166, 10.1034/j.1600-079X.2000.290306.x

Nicolson, 1988, Loss of intercellular junctional communication correlates with metastatic potential in mammary adenocarcinoma cells, Proc Natl Acad Sci USA, 85, 473, 10.1073/pnas.85.2.473

Mediavilla, 1992, Melatonin inhibits mammary gland development in female mice, J Pineal Res, 13, 13, 10.1111/j.1600-079X.1992.tb00049.x

Mediavilla, 1997, Effects of melatonin on mammary gland lesions in transgenic mice overexpressing N-ras proto-oncogene, J Pineal Res, 22, 86, 10.1111/j.1600-079X.1997.tb00308.x

Rato, 1999, Melatonin blocks the activation of estrogen receptor for DNA binding, FASEB J, 13, 857, 10.1096/fasebj.13.8.857

Aronika, 1994, Estrogen action via the cAMP signalling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription, Proc Natl Acad Sci USA, 91, 8517, 10.1073/pnas.91.18.8517

Godson, 1997, The mel1a melatonin receptor is coupled to parallel signal transduction pathways, Endocrinology, 138, 397, 10.1210/en.138.1.397

Kiefer, 2002, Melatonin inhibits estrogen receptor transactivation and cAMP levels in breast cancer cells, Breast Cancer Res Treat, 71, 37, 10.1023/A:1013301408464

García-Pedrero, 2002, Calmodulin is a selective modulator of estrogen receptors, Mol Endocrinol, 16, 947, 10.1210/me.16.5.947

Dai, 2002, Modulation of intracellular calcium and calmodulin by melatonin in MCF-7 human breast cancer cells, J Pineal Res, 32, 112, 10.1034/j.1600-079x.2002.1844.x

Del Rio, 2004, Melatonin: an endogenous specific inhibitor of estrogen receptor α via calmodulin, J Biol Chem, 279, 38294, 10.1074/jbc.M403140200

Conley, 2001, Mammalian aromatases, Reproduction, 121, 685, 10.1530/rep.0.1210685

Santen, 1999, Use of aromatase inhibitors in breast carcinoma, Endocr Relat Cancer, 6, 75, 10.1677/erc.0.0060075

Cos, 2005, Melatonin modulates aromatase activity in MCF-7 human breast cancer cells, J Pineal Res, 38, 136, 10.1111/j.1600-079X.2004.00186.x

Cos, 2006, Melatonin inhibits the growth of DMBA-induced mammary tumors by decreasing the local biosynthesis of estrogens through the modulation of aromatase activity, Int J Cancer, 118, 274, 10.1002/ijc.21401

Bulun, 2003, The human CYP 19 (aromatase p450) gene: update on physiologic roles and genomic organization of promoters, J Steroid Biochem Mol Biol, 86, 219, 10.1016/S0960-0760(03)00359-5

Cardinali, 1992, Diurnal changes in cyclic nucleotide response to pineal indoles in murine mammary glands, J Pineal Res, 13, 111, 10.1111/j.1600-079X.1992.tb00064.x